Ankur Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Kanpur, Uttar Pradesh, India, established in 1986.
1986 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Ankur Pharmaceuticals Private Limited

Ankur Pharmaceuticals Private Limited, a active private limited company, was established on 22 October 1986 in Kanpur, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231UP1986PTC008301. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.13 M.

It upholds a compliant status. Its leadership includes Shivani Bvhargava (Director), Sandeep Bhargava (Additional Director), Nupur Bhargava (Additional Director). Past directors included Madhu Bhargava, Shanti Devi Bhargava, Pratibha Bhargava. It holds no open charges and ₹1.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 15/295-C Civil Lines, Kanpur, Uttar Pradesh, 208001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231UP1986PTC008301

  • Registration Number

    008301

  • Incorporation Date

    22 October 1986

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.13 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.13 M
  • Company Age 39 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.50 M
  • Revenue Growth **** -15.17%
  • Profit Growth **** 60.64%
  • Ebitda **** 23.08%
  • Net Worth 45.65%
  • Total Assets **** 11.01%
Company report

Ankur Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ankur Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ankur Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Shivani Bvhargava Director 31 Oct 1998 Current
Sandeep Bhargava Additional Director 10 May 2021 Current
Nupur Bhargava Additional Director 14 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Jul 2025 Past
Pramod Abcsdd Director 07 Jun 2012 Past
Pramod Abcsdd Director 30 Jul 2018 Past
Pramod Abcsdd Managing Director 10 May 2021 Past
Pramod Abcsdd Director 10 Apr 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ankur Pharmaceuticals.

Ankur Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 15.17% decrease. The company also saw a substantial improvement in profitability, with a 60.64% increase in profit. The company's net worth Soared by an impressive increase of 45.65%.

Ankur Pharmaceuticals revenue growth over time
Ankur Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -15.17%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 11.01%
*******
*******
*******
*******
Profit or Loss
*******
 60.64%
*******
*******
*******
*******
Net Worth
*******
 45.65%
*******
*******
*******
*******
EBITDA
*******
 23.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ankur Pharmaceuticals?

In 2017, Ankur Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,500,000.00

Charges Breakdown by Lending Institutions
  • Icici Hfc Ltd. : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
31 Mar 2004 Icici Hfc Ltd. ₹1.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ankur Pharmaceuticals?

Unlock and access historical data on people associated with Ankur Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ankur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ankur Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ankur Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Ankur Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Nupur Bhargava was appointed as a Additional Director was appointed as a Additional Director on 14 Jul 2025 & has been associated with this company since 7 months . was recorded as a recent event.

  • Balance Sheet

    The activity Ankur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Director Appointment

    The activity Sandeep Bhargava was appointed as a Additional Director was appointed as a Additional Director on 10 May 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Charges

    A charge registered on 31 Mar 2004 via Charge ID 90270772 with Icici Hfc Ltd. was fully satisfied on 06 Apr 2011. was recorded as a recent event.

  • Charges

    A charge with Icici Hfc Ltd. amounted to Rs. 1.50 M with Charge ID 90270772 was registered on 31 Mar 2004. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ankur Pharmaceuticals Private Limited?

The CIN of Ankur Pharmaceuticals Private Limited is U24231UP1986PTC008301.

Where is Ankur Pharmaceuticals Private Limited headquartered?

Ankur Pharmaceuticals Private Limited is headquartered at 15/295-C Civil Lines, Kanpur, Uttar Pradesh, 208001.

When was Ankur Pharmaceuticals Private Limited incorporated?

Ankur Pharmaceuticals Private Limited was incorporated on 22 October 1986.

Who are the current directors of Ankur Pharmaceuticals Private Limited?

The current directors of Ankur Pharmaceuticals Private Limited are

What is the primary industry of Ankur Pharmaceuticals Private Limited?

The primary industry of Ankur Pharmaceuticals Private Limited is Pharma.

Is Ankur Pharmaceuticals Private Limited a listed company?

Ankur Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ankur Pharmaceuticals Private Limited?

The authorized capital of Ankur Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.13 M.

What is the compliance status of Ankur Pharmaceuticals Private Limited?

The compliance status of Ankur Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available